Deepbridge Exceeds £200m in Investments

11th October 2021

Deepbridge Capital has now exceeded £200 million of funds deployed across is EIS and Estate Planning Service funds, with a current Net Asset Value (NAV) of over £250 million.

Deepbridge Capital has, to date, invested in 71 companies across the UK with Enterprise Investment Scheme (EIS) funding, a further 63 companies at the Seed EIS stage, with three profitable exits. Deepbridge Capital launched its first EIS Fund in the 2013/14 tax year specialising in providing venture capital to early-stage technology, life sciences and renewable energy companies.

AlgaeCytes First Commercial Production Plant

22nd October 2021

One of Deepbridge Capitals Technology Growth EIS companies, AlgaeCytes Limited, was featured in Mitteldeutsche Zeitung (a regional daily newspaper for southern Saxony-Anhalt, Germany) highlighting AlgaeCytes project to build its first commercial production plant in Dessau, Germany.

Deepbridge Deploys £50M into UK Life Sciences Companies

27th October 2021

Deepbridge Capital has deployed over £50 million of capital into UK life sciences companies.

The Deepbridge Life Sciences EIS was launched in 2017 as our first life sciences focused EIS fund, providing private investors with access to a portfolio of early-stage investee companies across the biopharmaceutical, biotechnology, medical technology and digital healthcare sectors.